A model in which sustaining the effective potency of WLDS locally is required for its protective effects leaves open the possibility that Sarm1 deletion may be more effective than WldS at rescuing symptoms in models of other types of neurodegenerative disease, not just those with early neuromuscular symptoms. Here, SARM1 is linked to neurodegenerative disease.